company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3645808.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3645808.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,90076.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-88563.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1005325.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4649620.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4649620.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12405.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,11458.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-947.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-947.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-76603.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-76603.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-76603.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-49043.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4776213.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1611.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2679692.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2679692.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,74353.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-286051.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1001843.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3893233.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3893233.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-19814.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4001.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23815.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23815.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-58525.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-58525.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-58525.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,12577.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3962996.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,7474.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5085988.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5085988.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,79738.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,259612.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,871592.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3875046.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3875046.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,1097.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,119748.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,120845.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,120845.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-23236.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-23236.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-23236.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-19810.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3797247.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,168.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5186988.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5186988.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,24378.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1907966.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-434310.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3688954.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3688954.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5395.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,4652.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-743.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-743.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,29713851.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,29713850.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,29713850.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,26024153.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-3410.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10210148.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10210148.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,22650.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5289686.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-737861.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5635673.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5635673.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8664.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10243468.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2000000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8252132.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8252132.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,87428.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,87428.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,87428.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13800377.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13476917.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13476917.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29834.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,528463.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7462352.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-51914.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5508182.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5508182.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-31193.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49538795.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11997188.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37572800.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37572800.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,61379263.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2123324.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,63502587.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,63510688.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20429706.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,6935368.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31737073.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31737073.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,26886.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,547694.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23736980.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,988264.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6437249.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6437249.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-81348.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26449402.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12439494.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14091256.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14091256.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-209946.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2089498.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1879552.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1879552.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18648953.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-6935368.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12367862.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12367862.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,26630.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,538843.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1397982.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20489.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10424896.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10424896.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1507795.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-39593335.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30804318.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10297812.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10297812.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,594332.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20128376.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-246028828.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-246028828.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,61661.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,551913.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,234062320.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-965442.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12318376.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12318376.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-299808.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15723676.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23729896.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7706412.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7706412.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-338816.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2798428.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2459612.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2459612.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2152352.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,33469828.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33469828.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,68339.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,818087.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-52000320.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1766558.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19410624.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19410624.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-322192.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-145628324.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13558104.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-132392412.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-132392412.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,338816.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,183546000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1667572.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,185552388.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,185552388.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33750352.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35843000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35843000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,80000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1021000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5255000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5622000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23865000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23866000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3068000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34625000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32757000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4936000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4936000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-71000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1972000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1901000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1901000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26902000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34824000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34824000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,233000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,975000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3662000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2190000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32144000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32143000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-953000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8367000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,42357000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,33037000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,33037000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1070000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1070000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1070000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1964000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39386000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39386000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,250000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,884000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9738000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1079000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29594000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29594000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1930000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-122214000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43620000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-80524000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-80524000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,191634000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2989000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,194623000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,194623000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-162000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,84343000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47894000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47894000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,396000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1711000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6631000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5154000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34001000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34001000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2247000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-401840000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,52798000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-351289000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-351289000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,367296000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1547000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,368843000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,368843000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,338000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16109000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50895000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50895000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,413000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1922000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5669000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9272000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33619000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33619000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1237000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35874000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54635000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17524000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17524000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-174000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1059000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,885000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,885000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-690000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15900000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-88254000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-88254000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,632000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1785000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12151000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7998000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-65688000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-65688000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-521000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-80781000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,106119000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,24817000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,24817000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1118000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1118000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1118000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,138000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-39615000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-126674000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-126674000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,684000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1543000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10244000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,44346000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-69857000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-69857000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2407000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35318000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,123006000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,85281000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,85281000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1486000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1486000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1486000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-447000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16463000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-77299000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-77299000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,860000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1121000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4253000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,45000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-71020000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-71020000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1780000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,119111000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-45000000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,72331000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,72331000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1420000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1420000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1420000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-235000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2496000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-88816000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-88816000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,643000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1398000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15597000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-40924000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-112102000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-112102000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,182000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-408005000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,118902000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,45000000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-243921000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-243921000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,447715000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-36841000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,410874000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,410874000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1336000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,53515000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-120041000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-120041000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1644000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1562000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22401000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4972000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-89462000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-89462000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1074000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-68198000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,95446000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,26174000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,26174000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-142000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,744000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,602000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,602000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1145000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-61541000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-89930000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-89930000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,802000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1365000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17187000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6924000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-77500000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-77500000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4025000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-21246000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,125285000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,100014000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,100014000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,556000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,556000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,556000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,205000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23275000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-86564000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-86564000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1072000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1255000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17477000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11455000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-55305000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-55305000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4213000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-59452000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,111628000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,970000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,48933000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,48933000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1091000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1091000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1091000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,362000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4919000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72601000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72601000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1382000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1209000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16496000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2624000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-56138000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-56138000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1864000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46304000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,161630000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-29000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,113433000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,113433000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,430000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,430000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,430000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,488000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,58213000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-111272000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-111272000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1345000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1017000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19712000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12739000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-76459000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-76459000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-290000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-104105000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,130731000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-941000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,25395000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,25395000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,761000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,761000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,761000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1055000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-51358000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-81590000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-81590000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1290000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,875000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16605000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-26046000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-88866000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-88866000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-89000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28466000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,95273000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,66718000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,66718000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,481000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,481000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,481000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,525000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21142000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-75193000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-75193000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1138000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,412000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18265000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7923000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-47455000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-47455000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,44000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-266071000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,82768000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-183259000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-183259000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,261357000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,261362000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,261362000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1799000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,28849000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-64454000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64454000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1123000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,123000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15169000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3542000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-51581000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-51581000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-83724000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,115266000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31542000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31542000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-261357000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,261362000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1257000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1262000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1262000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,439000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18338000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-88005000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-88005000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1031000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,99000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15245000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18818000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-52812000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-52812000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-122000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-57810000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,94861000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,36929000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,36929000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,440000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,440000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,440000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,835000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14608000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-90270000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-90270000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,996000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,107000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19046000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13304000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-83425000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-83425000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-733000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5212000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,100412000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,94467000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,94467000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,152000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,152000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,152000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11194000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-71420000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-71420000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3614000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,281000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16676000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4901000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-45948000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-45948000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-291000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-446690000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,81163000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-365818000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-365818000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,223424000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,227200000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-9000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,450615000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,450595000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,230000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,39059000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-84833000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-84833000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-1771000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,546000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,21780000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17522000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-46756000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-46756000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-108831000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,125323000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16475000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16475000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,892000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,892000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,892000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-735000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30124000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-98158000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-98158000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,824000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,894000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18977000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16979000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-60484000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-60484000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-95000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42281000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,108264000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,65888000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,65888000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,60000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5800000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5860000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5880000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,505000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11789000.0
